NCT03926416View on ClinicalTrials.gov

Safety Study of Live Attenuated Influenza Vaccine, CodaVax

PHASE1CompletedINTERVENTIONAL
Enrollment

125

Participants

Timeline

Start Date

February 21, 2017

Primary Completion Date

May 29, 2018

Study Completion Date

September 14, 2018

Conditions
Influenza
Interventions
BIOLOGICAL

CodaVax-H1N1

Live-attenuated vaccine against influenza A H1N1, A/California/07/2009

BIOLOGICAL

Fluzone quadrivalent

Fluzone® (QuadriFlu - TIV), inactivated, quadrivalent influenza vaccine

Trial Locations (1)

4006

Q-Pharm, Herston

Sponsors

Lead Sponsor

Codagenix, Inc
All Listed Sponsors
lead

Codagenix, Inc

INDUSTRY